These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31646822)

  • 21. Risk group stratification to predict recurrence after transurethral resection in Japanese patients with stage Ta and T1 bladder tumours: validation study on the European Association of Urology guidelines.
    Sakano S; Matsuyama H; Takai K; Yoshihiro S; Kamiryo Y; Shirataki S; Kaneda Y; Hashimoto O; Joko K; Suga A; Yamamoto M; Hayashida S; Baba Y; Aoki A;
    BJU Int; 2011 May; 107(10):1598-604. PubMed ID: 21087393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
    May M; Helke C; Nitzke T; Vogler H; Hoschke B
    Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review.
    Rouprêt M; Seisen T; Compérat E; Larré S; Mazerolles C; Gobet F; Fetissof F; Fromont G; Safsaf A; d'Arcier BF; Celhay O; Validire P; Rozet F; Irani J; Soulié M; Pfister C;
    J Urol; 2013 Jun; 189(6):2069-76. PubMed ID: 23201497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors Associated with Re-Resection in T1 Bladder Cancer: Identifying Patients Who Do Not Receive Guideline-Concordant Care at the Population Level.
    Wettstein MS; Baxter NN; Sutradhar R; Mamdani M; Song P; Qadri SR; Bhalla G; Li K; Liu N; van der Kwast T; Hermanns T; Kulkarni GS
    J Urol; 2022 Feb; 207(2):314-323. PubMed ID: 34547923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obesity is associated with worse outcomes in patients with T1 high grade urothelial carcinoma of the bladder.
    Kluth LA; Xylinas E; Crivelli JJ; Passoni N; Comploj E; Pycha A; Chrystal J; Sun M; Karakiewicz PI; Gontero P; Lotan Y; Chun FK; Fisch M; Scherr DS; Shariat SF
    J Urol; 2013 Aug; 190(2):480-6. PubMed ID: 23376707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monopolar vs. bipolar transurethral resection for non-muscle invasive bladder carcinoma: A post-hoc analysis from a randomized controlled trial.
    Liem EIML; McCormack M; Chan ESY; Matsui Y; Geavlete P; Choi YD; de Reijke TM; Farahat Y; Inman BA; de la Rosette JJMCH; Naito S
    Urol Oncol; 2018 Jul; 36(7):338.e1-338.e11. PubMed ID: 29661592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of age on the efficacy of maintenance bacillus Calmette-Guérin relative to maintenance epirubicin in patients with stage Ta T1 urothelial bladder cancer: results from EORTC genito-urinary group study 30911.
    Oddens JR; Sylvester RJ; Brausi MA; Kirkels WJ; van de Beek C; van Andel G; de Reijke TM; Prescott S; Witjes JA; Oosterlinck W
    Eur Urol; 2014 Oct; 66(4):694-701. PubMed ID: 24948466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of body mass on recurrence and progression in Chinese patients with Ta, T1 urothelial bladder cancer.
    Xu T; Zhu Z; Wang X; Xia L; Zhang X; Zhong S; Sun F; Zhu Y; Shen Z
    Int Urol Nephrol; 2015 Jul; 47(7):1135-41. PubMed ID: 26009259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility and Clinical Roles of Different Substaging Systems at First and Second Transurethral Resection in Patients with T1 High-Grade Bladder Cancer.
    Colombo R; Hurle R; Moschini M; Freschi M; Colombo P; Colecchia M; Ferrari L; Lucianò R; Conti G; Magnani T; Capogrosso P; Conti A; Pasini L; Burgio G; Guazzoni G; Patriarca C
    Eur Urol Focus; 2018 Jan; 4(1):87-93. PubMed ID: 28753746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of smoking status on bladder tumor recurrence after radical nephroureterectomy for upper tract urothelial carcinoma.
    Hagiwara M; Kikuchi E; Tanaka N; Matsumoto K; Ide H; Miyajima A; Masuda T; Nakamura S; Oya M
    J Urol; 2013 Jun; 189(6):2062-8. PubMed ID: 23328579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Radical cystectomy in the treatment of bladder cancer always in due time?].
    May M; Braun KP; Richter W; Helke C; Vogler H; Hoschke B; Siegsmund M
    Urologe A; 2007 Aug; 46(8):913-9. PubMed ID: 17676301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive Factors for Residual Cancer in Second Transurethral Resection for Non-muscle-invasive Bladder Cancer.
    Akitake M; Yamaguchi A; Shiota M; Imada K; Tatsugami K; Yokomizo A; Naito S; Eto M
    Anticancer Res; 2019 Aug; 39(8):4325-4328. PubMed ID: 31366524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.
    Koie T; Ohyama C; Hosogoe S; Yamamoto H; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Yoneyama T; Tobisawa Y; Mori K
    Int Urol Nephrol; 2015 Sep; 47(9):1509-14. PubMed ID: 26149637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrence at three months and high-grade recurrence as prognostic factor of progression in multivariate analysis of T1G2 bladder tumors.
    Palou J; Rodríguez-Rubio F; Millán F; Algaba F; Rodríguez-Faba O; Huguet J; Villavicencio H
    Urology; 2009 Jun; 73(6):1313-7. PubMed ID: 19362341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. En bloc re-resection of high-risk NMIBC after en bloc resection: results of a multicenter observational study.
    Hurle R; Casale P; Lazzeri M; Paciotti M; Saita A; Colombo P; Morenghi E; Oswald D; Colleselli D; Mitterberger M; Kunit T; Hager M; Herrmann TRW; Lusuardi L
    World J Urol; 2020 Mar; 38(3):703-708. PubMed ID: 31114949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer.
    Matsumoto A; Nakagawa T; Kanatani A; Ikeda M; Kawai T; Miyakawa J; Taguchi S; Naito A; Otsuka M; Nakanishi Y; Suzuki M; Koga F; Nagase Y; Kondo Y; Okaneya T; Tanaka Y; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
    World J Urol; 2018 Feb; 36(2):249-256. PubMed ID: 29185045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic kidney disease as an important risk factor for tumor recurrences, progression and overall survival in primary non-muscle-invasive bladder cancer.
    Li CE; Chien CS; Chuang YC; Chang YI; Tang HP; Kang CH
    Int Urol Nephrol; 2016 Jun; 48(6):993-9. PubMed ID: 26995008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of surgical experience on recurrence and progression after transurethral resection of bladder tumour in non-muscle-invasive bladder cancer.
    Jancke G; Rosell J; Jahnson S
    Scand J Urol; 2014 Jun; 48(3):276-83. PubMed ID: 24286506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The evaluation of the risk factors for non-muscle invasive bladder cancer (NMIBC) recurrence after transurethral resection (TURBt) in Chinese population.
    Liu S; Hou J; Zhang H; Wu Y; Hu M; Zhang L; Xu J; Na R; Jiang H; Ding Q
    PLoS One; 2015; 10(4):e0123617. PubMed ID: 25849552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local recurrence and progression of non-muscle-invasive bladder cancer in Sweden: a population-based follow-up study.
    Liedberg F; Hagberg O; Holmäng S; Hosseini Aliabad A; Jancke G; Ljungberg B; Malmström PU; Åberg H; Jahnson S
    Scand J Urol; 2015; 49(4):290-5. PubMed ID: 25624049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.